NCT01134042 - Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics | Biotech Hunter

Enrollment

587

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Asthma

Interventions

DRUG

Fluticasone Furoate/Vilanterol Inhalation Powder

Fluticasone furoate/Vilanterol inhalation powder inhaled orally once daily for 24 weeks

DRUG

Fluticasone Furoate Inhalation Powder

Fluticasone furoate inhalation powder inhaled orally once daily for 24 weeks

DRUG

Fluticasone Propionate Inhalation Powder

Fluticasone propionate inhalation powder inhaled orally twice daily for 24 weeks

OTHER

Placebo Inhalation Powder 1

Placebo in novel dry powder inhaler once daily

OTHER

Placebo Inhalation Powder 2

Placebo in Diskus inhaler twice daily

Trial Locations (71)

16303

GSK Investigational Site, Schwedt

20354

GSK Investigational Site, Hamburg

21502

GSK Investigational Site, Geesthacht

23552

GSK Investigational Site, Lübeck

28801

GSK Investigational Site, Asheville

29118

GSK Investigational Site, Orangeburg

30167

GSK Investigational Site, Hanover

30342

GSK Investigational Site, Atlanta

32405

GSK Investigational Site, Panama City

33173

GSK Investigational Site, Miami

33756

GSK Investigational Site, Clearwater

34121

GSK Investigational Site, Kassel

45231

GSK Investigational Site, Cincinnati

60305

GSK Investigational Site, River Forest

60389

GSK Investigational Site, Frankfurt am Main

61761

GSK Investigational Site, Normal

63571

GSK Investigational Site, Gelnhausen

65428

GSK Investigational Site, Rüsselsheim am Main

73103

GSK Investigational Site, Oklahoma City

73112

GSK Investigational Site, Oklahoma City

77479

GSK Investigational Site, Sugar Land

78756

GSK Investigational Site, Austin

79925

GSK Investigational Site, El Paso

90048

GSK Investigational Site, Los Angeles

90201

GSK Investigational Site, Bell Gardens

90808

GSK Investigational Site, Long Beach

92128

GSK Investigational Site, San Diego

92506

GSK Investigational Site, Riverside

92647

GSK Investigational Site, Huntington Beach

95661

GSK Investigational Site, Roseville

97035

GSK Investigational Site, Lake Oswego

97504

GSK Investigational Site, Medford

100550

GSK Investigational Site, Ploieşti

115446

GSK Investigational Site, Moscow

123182

GSK Investigational Site, Moscow

125367

GSK Investigational Site, Moscow

127018

GSK Investigational Site, Moscow

198216

GSK Investigational Site, Saint Petersburg

214001

GSK Investigational Site, Smolensk

300310

GSK Investigational Site, Timișoara

390026

GSK Investigational Site, Ryazan

410176

GSK Investigational Site, Oradea

420015

GSK Investigational Site, Kazan'

620109

GSK Investigational Site, Yekaterinburg

700115

GSK Investigational Site, Iași

720284

GSK Investigational Site, Suceava

03050

GSK Investigational Site, Cottbus

811-1394

GSK Investigational Site, Fukuoka

732-0052

GSK Investigational Site, Hiroshima

672-8048

GSK Investigational Site, Hyōgo

920-8530

GSK Investigational Site, Ishikawa

762-0031

GSK Investigational Site, Kagawa

603-8161

GSK Investigational Site, Kyoto

712-8064

GSK Investigational Site, Okayama

901-2132

GSK Investigational Site, Okinawa

430-8558

GSK Investigational Site, Shizuoka

438-8550

GSK Investigational Site, Shizuoka

105-0003

GSK Investigational Site, Tokyo

158-0083

GSK Investigational Site, Tokyo

15-010

GSK Investigational Site, Bialystok

13-200

GSK Investigational Site, Działdowo

80-169

GSK Investigational Site, Gdansk

84-462

GSK Investigational Site, Gdansk

44-100

GSK Investigational Site, Gliwice

31-202

GSK Investigational Site, Krakow

41-940

GSK Investigational Site, Piekary Śląskie

81-741

GSK Investigational Site, Sopot

020125

GSK Investigational Site, Bucharest

030317

GSK Investigational Site, Bucharest

115 280

GSK Investigational Site, Moscow

Unknown

GSK Investigational Site, Yaroslavl